Literature DB >> 12920049

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

Anatol Kontush1, Sandrine Chantepie, M John Chapman.   

Abstract

OBJECTIVE: The relationship of the structural and functional heterogeneity of HDL particles to protection of LDL against oxidative stress is indeterminate. METHODS AND
RESULTS: HDL subfractions of defined physicochemical properties were isolated by density gradient ultracentrifugation from normolipidemic human serum (n=8), and their capacity to protect LDL from oxidation was evaluated. Under mild oxidative stress induced by AAPH or Cu(II), HDL subfractions (at equal cholesterol or protein concentration or equal particle number) significantly decreased LDL oxidation rate (-20% to -85%) in the propagation phase (234 nm), which was prolonged by up to 82% with decreased maximal diene formation. Antioxidative activity of HDL subfractions increased with increment in density, as follows: HDL2b<HDL2a<HDL3a<HDL3b<HDL3c (confirmed by thiobarbituric acid-reactive substance content and LDL electrophoretic mobility). Concordantly, antioxidative activity of small HDL prepared by FPLC was significantly higher (+56%) than that of large HDL. Antioxidative action of HDL subfractions was primarily associated with inactivation of LDL lipid hydroperoxides. The potent protective activity of small HDL could not be accounted for exclusively by enzymatic activities (PON1, platelet-activating factor acetylhydrolase, and lecithin-cholesterol acyltransferase).
CONCLUSIONS: Small, dense HDL exhibit potent antioxidant activity, which may arise from synergy in inactivation of oxidized LDL lipids by enzymatic and nonenzymatic mechanisms, in part reflecting distinct intrinsic physicochemical properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920049     DOI: 10.1161/01.ATV.0000091338.93223.E8

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  126 in total

1.  Clinical applications of advanced lipoprotein testing in diabetes mellitus.

Authors:  Danyaal S Moin; Anand Rohatgi
Journal:  Clin Lipidol       Date:  2011-08-01

Review 2.  Lesions and lipids and radicals--O my!

Authors:  James M Wilson; Brian Walton
Journal:  Tex Heart Inst J       Date:  2004

Review 3.  Lipidomics as a tool for the study of lipoprotein metabolism.

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

Review 4.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

5.  LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.

Authors:  Alexina Orsoni; Samir Saheb; Johannes H M Levels; Geesje Dallinga-Thie; Marielle Atassi; Randa Bittar; Paul Robillard; Eric Bruckert; Anatol Kontush; Alain Carrié; M John Chapman
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

Review 6.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

7.  Urinary apolipoprotein AI in children with kidney disease.

Authors:  Amanda J Clark; Kathy Jabs; Tracy E Hunley; Deborah P Jones; Rene G VanDeVoorde; Carl Anderson; Liping Du; Jianyong Zhong; Agnes B Fogo; Haichun Yang; Valentina Kon
Journal:  Pediatr Nephrol       Date:  2019-06-23       Impact factor: 3.714

8.  Effects of acyl chain length, unsaturation, and pH on thermal stability of model discoidal HDLs.

Authors:  Madhumita Guha; Donald L Gantz; Olga Gursky
Journal:  J Lipid Res       Date:  2008-05-01       Impact factor: 5.922

9.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22

10.  Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Maciej Banach; Magdalena Rysz-Górzyńska
Journal:  Int Urol Nephrol       Date:  2016-12-09       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.